Antibacterial properties of silver chelates of uracil and uracil derivatives in vitro.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000633:toxicity; D001412:Bacillus subtilis / Q000187:drug effects / Q000378:metabolism; D001976:Bromouracil / Q000494:pharmacology; D002417:Cattle; D002499:Centrifugation, Density Gradient; D002614:Chelating Agents / Q000494:pharmacology* / Q000633:toxicity; D004269:DNA, Bacterial / Q000378:metabolism; D004285:Dogs; D005260:Female; D008297:Male; D051379:Mice; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D012834:Silver / Q000494:pharmacology* / Q000633:toxicity; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013941:Thymine / Q000494:pharmacology; D014498:Uracil / Q000494:pharmacology* / Q000633:toxicity; D014529:Uridine / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D002614:Chelating Agents; D004269:DNA, Bacterial; D012834:Silver; D001976:Bromouracil; D014498:Uracil; D013941:Thymine; D014529:Uridine